一般演題（口演）18 免疫チェックポイント阻害剤（臨床試験）

[O18-5] Cemiplimab Alone or with Chemotherapy in Japanese Patients with Advanced Non-Small Cell Lung Cancer

^○Yuki Sato¹, Yoko Tani², Hidenobu Ishii³, Seigo Katakura⁴, Masahide Oki⁵, Yasutaka Watanabe⁶, Toshihide Yokoyama⁷, Katsuhiko Naoki⁸, Jean-Francois Pouliot⁹, Anne Paccaly⁹, Eric Kim⁹, Jayakumar Mani⁹, Siyu Li⁹, Israel Lowy⁹, Frank Seebach⁹, Melissa Mathias⁹, Satoshi Ikeda¹⁰ (1.Kobe City Medical Center General Hospital, 2.Osaka Metropolitan University Hospital, 3.Kurume University Hospital, 4.Kanagawa Cancer Center, 5.National Hospital Organization Nagoya Medical Center, 6.Saitama Cancer Center, 7.Kurashiki Central Hospital, 8.Kitasato University Hospital, 9.Regeneron Pharmaceuticals, Inc., 10.Kanagawa Cardiovascular and Respiratory Center)

アンコール演題